Building the Roadmap for Regenerative Medicine

RESTORE community meets to finalise the Advanced Therapies Roadmap for Horizon Europe

RESTORE

SHARE THIS STORY:

RESTORE is a large-scale research initiative that aims at to make the promise of advanced therapies (cell and gene therapies, tissue engineering products) a reality for the benefit of patients and society, making Europe a spearhead in the application of advanced therapies.

 

Two months after the official launch, the RESTORE core partners and supporters gathered in Berlin to flesh out the details of the “Advanced Therapies Roadmap for Horizon Europe”, its mission to create a pipeline of ‘made in Europe’ advanced therapy products  over the next 10 years.

 

At the kick-off, RESTORE founders presented the main fields RESTORE plans to be active in: manufacturing, preclinical and clinical development, regulatory, market access, economics and ethics of advanced therapies. About 200 supporters from academia, industry and patient advocacy groups participated in the two-day event and joined a total of 17 working groups that commenced their discussions to identify challenges and roadblocks slowing down progress in the field.

 

After the event, discussions moved online where the community is debating putative solutions and jointly developing a community-driven strategy that will propose a suitable configuration and sustainable funding for RESTORE.

 

This unusual bottom-up approach was favoured by the organisers for two reasons. First, due to the ambition of the mission, there is a need to bring in people and expertise from the entire European Union and beyond. Second, there are many – albeit scattered – successes and best‑practice cases around advanced therapies that can be leveraged and built upon.

 

The organisers were also proud to report that the RESTORE community continues to grow, currently with more than 300 supporters from academic institutions, companies, initiatives and patient organisations.

 

RESTORE has received funding from the European Union’s Horizon 2020 research and innovation FET programme under grant agreement No 820292.

 

Photo by Ibrahim Boran on Unsplash